Emphysema - 52 Studies Found

Completed : Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
:
  • Alpha-1 Antitrypsin Deficiency
  • Emphysema
  • Chronic Obstructi
    : 2016-12-22
    :
    • Drug: Aspirin 81mg aspirin tak
Withdrawn : Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency
:
  • Alpha-1-Antitrypsin Deficiency
  • Chronic Obstructive Lung Disease
  • Lung Diseases
  • Emphysema
  • Alpha-1 Antitrypsin Deficiency : 2000-05-25
Completed : Stage 1 Study of ARALAST NP and GLASSIA in A1PI
:
  • Chronic Obstructive Pulmonary Disease
  • Alpha1-antitrypsin Deficiency

: 2016-03-23
:
  • Biological: ARALAST NP 60 mg/kg

Active, not recruiting : A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease
: Antitrypsin Deficiency Liver Disease
: 2015-07-16
:
  • Drug: ALN-AAT Single or multip
Completed : Environment Effect on Six-Minute Walk Test Performance
:
  • Chronic Obstructive Pulmonary Disease
  • Alpha-1 Antitrypsin Deficiency

: 2015-06-09
:
  • Other: six-minute walk study indoors

Completed : Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients
:
  • Chronic Obstructive Pulmonary Disease
  • Alpha-1-antitrypsin-deficiency

: 2011-06-22
: Procedure: exercise training strength and endurance training, 5 time per week.
Completed : Ph 3/4 GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study
: Alpha1-antitrypsin Deficiency
: 2015-08-14
: Biological: GLASSIA 60 mg/kg BW administered at a rate of 0.2 mL/kg/min
COMPLETED : Assessing the DIAphragM Before ANd After Endobronchial Valve Treatment
: Emphysema
: 2025-08-03
: Echography of diaphragma and other respiratory muscles
Completed : Smoking Cessation and Functional CT Assessment
: Emphysema
: 2025-08-03
: Sildenafil, 20mg three times daily for 3 month period.
<<< Previous | Next >>>